Rodes Biopharma ApS: Financial statements 2022
CVR: 42425990
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Rodes Biopharma ApS (CVR 42425990) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 486,825 and a net result of DKK 389,813. Equity in the 2022 report amounted to DKK 483,027. The solvency ratio was 46.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 486,825
- Profit/Loss
- DKK 389,813
- Equity
- DKK 483,027
- Total Assets
- DKK 1,029,384
- Employees
- 1
Official annual report
Keep an eye on Rodes Biopharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Rodes Biopharma ApS has published its interim report for the period June 1, 2021 to December 31, 2021.
As of April 26, 2022, Jens Bo Rode Hansen is registered as an owner of Rodes Biopharma ApS with an ownership share of 50%.
As of April 26, 2022, Gitte Rode is registered as an owner of Rodes Biopharma ApS with an ownership share of 50%.
As of February 28, 2022, Gitte Rode has joined the board of directors of Rodes Biopharma ApS.
About Rodes Biopharma ApS
Rodes Biopharma ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Rodes ApS. The management consists of Jens Bo Rode Hansen. The board consists of Gitte Rode. The company is owned by Jens Bo Rode Hansen and Gitte Rode. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 3,592,336 and a net result of DKK 1,503,450 compared with DKK 93,839 the year before. Equity in the 2025 report amounted to DKK 1,863,111.